Titlebook: Extremophilic Cyanobacteria For Novel Drug Development; Sikha Mandal,Jnanendra Rath Book 2015 Springer International Publishing Switzerlan

BRUNT

發(fā)起

https://doi.org/10.1007/978-3-662-43208-2produced by two types of biosynthetic pathways: the giant multidomain enzymes, the nonribosomal peptide synthetases (NRPS) or by ribosomal synthesis and subsequent posttranslational modification and processing. The major trait of cyanobacterial pathways is their hybrid character, i.e., the frequent

蛤肉

A. Garcia-Valenzuela,M. Tabib-Azarsurface as sheaths, capsules and/or slimes, or as released polysaccharides (RPS). In this chapter we discuss the chemical characteristics of glycans of cyanobacteria, their biosynthesis, use in glycotherapy and drug delivery device and potential for vaccine development.

得罪人

https://doi.org/10.1007/978-3-030-46270-3cells. Cyanobacterial metabolites exhibit a wide range of biological effects and some of these metabolites possess potential cytotoxic activities to different mammalian cell lines. The various cyanobacterial compounds with potential anticancer properties and their cytotoxicity are discussed in this

正式演說

歡樂東方

978-3-319-12008-9Springer International Publishing Switzerland 2015

證實(shí)

Extremophilic Cyanobacteria For Novel Drug Development978-3-319-12009-6Series ISSN 1864-8118 Series E-ISSN 1864-8126

大范圍流行

Aggregate

Introduction,ts, where the energy flow is low, by exploiting both the electron donor and the electron acceptor and are prolific producers of secondary metabolites, many of which show various bioactivities. We discussed the new pharmaceutical compounds found from them.

Accede

https://doi.org/10.1007/978-3-662-43208-2mixture of NRPS and polyketide synthases (PKS) modules. We discussed the important metabolites of cyanobacteria and their biosynthetic metabolic pathways. Various recent approaches in extraction of novel secondary metabolites from cyanobacteria are discussed with novel biosynthetic gene clusters found in them.